Menu Search
Equities

Vitura Health Ltd

VIT:ASX

Vitura Health Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.076
  • Today's Change0.00 / 0.00%
  • Shares traded75.99k
  • 1 Year change-75.48%
  • Beta0.7827
Data delayed at least 20 minutes, as of Sep 20 2024 06:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Vitura Health Ltd had net income fall -74.57% from 13.81m to 3.51m despite a 5.56% increase in revenues from 117.34m to 123.87m. An increase in the cost of goods sold as a percentage of sales from 65.45% to 72.37% was a component in the falling net income despite rising revenues.
Gross margin27.63%
Net profit margin2.62%
Operating margin3.68%
Return on assets5.50%
Return on equity9.52%
Return on investment7.70%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Vitura Health Ltd fell by 7.50m. However, the company earned 7.00m from its operations for a Cash Flow Margin of 5.65%. In addition the company used 13.20m on investing activities and also paid 1.30m in financing cash flows.
Cash flow per share0.0085
Price/Cash flow per share8.96
Book value per share0.0674
Tangible book value per share0.0131
More ▼

Balance sheet in AUDView more

Vitura Health Ltd has a Debt to Total Capital ratio of 22.28%, a higher figure than the previous year's 2.98%.
Current ratio1.33
Quick ratio1.11
Total debt/total equity0.2842
Total debt/total capital0.2228
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.